Key result
Transcatheter transatrial tricuspid valve-in-valve succeeds without residual leakage in a high-risk bioprosthesis dysfunction case.
Case Report (n=1)
Transcatheter transatrial tricuspid valve-in-valve is a feasible alternative for high-risk patients with dysfunctional tricuspid bioprostheses.
No takes yet. Share an insight, caveat, or question.
May expand options for high-risk tricuspid bioprosthesis dysfunction; leaves open safety, durability, and efficacy in larger prospective studies.
Gaia et al. (2012) conducted a case report in Tricuspid bioprosthesis dysfunction (n=1). Transcatheter transatrial tricuspid valve-in-valve procedure was evaluated on Procedural success (residual leakage and mean gradient). Transcatheter transatrial tricuspid valve-in-valve procedure was successful with no residual leakage and a non-significant mean gradient in a high-risk patient with bioprosthesis dysfunction.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: